NCT06812507 Evaluation of Placental Transfusion Techniques in Prevention of Prematurity Related Complications and Effect on Their Hematological Profile
| NCT ID | NCT06812507 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Alexandria University |
| Condition | Premature |
| Study Type | INTERVENTIONAL |
| Enrollment | 160 participants |
| Start Date | 2025-03-10 |
| Primary Completion | 2026-03-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 160 participants in total. It began in 2025-03-10 with a primary completion date of 2026-03-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to evaluate the general course and prognosis associated with different methods of placental transfusion (Intact umbilical cord milking, cut- umbilical cord milking and delayed cord clamping) in premature neonates over the first days of life
Eligibility Criteria
* Inclusion Criteria: 1. Premature neonates ≤ 32 weeks gestational age regardless birth weight 2. patients should be admitted to neonatal intensive care unit in the first day of life of life Exclusion criteria: * Exclusion Criteria: Patient with any of the following will be excluded: 1. Major congenital anomalies (complex cyanotic heart disease, major central nervous system anomalies). 2. Evidence of head trauma causing major intracranial hemorrhage. 3. placental abnormalities like : abruptions, placenta previa or retroplacental hematoma. 4. Cord accident, or avulsion at the time of delivery. 5. Refusal to perform the intervention by the obstetrician
Frequently Asked Questions
Who can join the NCT06812507 clinical trial?
This trial is open to participants of all sexes, aged 1 Minute or older, up to 2 Minutes, studying Premature. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06812507 currently recruiting?
Yes, NCT06812507 is actively recruiting participants. Visit ClinicalTrials.gov or contact Alexandria University to inquire about joining.
Where is the NCT06812507 trial being conducted?
This trial is being conducted at Alexandria, Egypt.
Who is sponsoring the NCT06812507 clinical trial?
NCT06812507 is sponsored by Alexandria University. The trial plans to enroll 160 participants.